Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Fitzpatrick

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
International Health|March 5, 2016
Leaving no one behind: a neglected tropical disease indicator and tracers for the Sustainable Development GoalsChristopher Fitzpatrick, Dirk Engels
Pharmacoeconomics|November 11, 2011
A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosisChristopher Fitzpatrick, Katherine Floyd
Nature|July 29, 2016
Sustainable Development Goals: diseases that neglect no goalsChristopher Fitzpatrick, Mathieu Bangert, Dirk Engels
Plos Neglected Tropical Diseases|September 26, 2014
Eradication of yaws: historical efforts and achieving WHO's 2020 targetKingsley Asiedu, Christopher Fitzpatrick, Jean Jannin
Plos Neglected Tropical Diseases|September 26, 2014
Where the road ends, yaws begins? The cost-effectiveness of eradication versus more roadsChristopher Fitzpatrick, Kingsley Asiedu, Jean Jannin
The Lancet. Global Health|August 9, 2014
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targetsKatherine Floyd, Christopher Fitzpatrick, Andrea Pantoja, et al.
The European Respiratory Journal|December 22, 2012
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysisAndrea Pantoja, Christopher Fitzpatrick, Anna Vassall, et al.
Cost Effectiveness and Resource Allocation : C/E|March 22, 2018
Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service deliveryKarin Stenberg, Jeremy A Lauer, Georgios Gkountouras, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 25, 2017
Preventive chemotherapy in one year reduces by over 80% the number of individuals with soil-transmitted helminthiases causing morbidity: results from meta-analysisChiara Marocco, Mathieu Bangert, Serene A Joseph, et al.
Infectious Diseases of Poverty|April 5, 2017
The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goalsMathieu Bangert, David H Molyneux, Steve W Lindsay, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
International Health|March 5, 2016
Leaving no one behind: a neglected tropical disease indicator and tracers for the Sustainable Development GoalsChristopher Fitzpatrick, Dirk Engels
Pharmacoeconomics|November 11, 2011
A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosisChristopher Fitzpatrick, Katherine Floyd
Nature|July 29, 2016
Sustainable Development Goals: diseases that neglect no goalsChristopher Fitzpatrick, Mathieu Bangert, Dirk Engels
Plos Neglected Tropical Diseases|September 26, 2014
Eradication of yaws: historical efforts and achieving WHO's 2020 targetKingsley Asiedu, Christopher Fitzpatrick, Jean Jannin
Plos Neglected Tropical Diseases|September 26, 2014
Where the road ends, yaws begins? The cost-effectiveness of eradication versus more roadsChristopher Fitzpatrick, Kingsley Asiedu, Jean Jannin
The Lancet. Global Health|August 9, 2014
Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targetsKatherine Floyd, Christopher Fitzpatrick, Andrea Pantoja, et al.
The European Respiratory Journal|December 22, 2012
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysisAndrea Pantoja, Christopher Fitzpatrick, Anna Vassall, et al.
Cost Effectiveness and Resource Allocation : C/E|March 22, 2018
Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service deliveryKarin Stenberg, Jeremy A Lauer, Georgios Gkountouras, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 25, 2017
Preventive chemotherapy in one year reduces by over 80% the number of individuals with soil-transmitted helminthiases causing morbidity: results from meta-analysisChiara Marocco, Mathieu Bangert, Serene A Joseph, et al.
Infectious Diseases of Poverty|April 5, 2017
The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goalsMathieu Bangert, David H Molyneux, Steve W Lindsay, et al.
Pageof 5